Potential nontraditional applications of statins (Q35169445)

6 August 2017

1 reference

title

Potential nontraditional applications of statins (English)

1 reference

6 August 2017

James M McKenney

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Annals of Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

37

1 reference

6 August 2017

issue

7-8

1 reference

6 August 2017

page(s)

1063-1071

1 reference

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

6 August 2017

cites work

1 reference

Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

Early statin therapy for acute coronary syndromes

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

The role of carotid arterial intima-media thickness in predicting clinical coronary events

21 January 2018

1 reference

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness

21 January 2018

1 reference

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

21 January 2018

1 reference

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy

21 January 2018

1 reference

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy

21 January 2018

1 reference

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

21 January 2018

1 reference

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

21 January 2018

1 reference

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease

21 January 2018

1 reference

Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease

21 January 2018

1 reference

Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies

21 January 2018

1 reference

Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention

21 January 2018

1 reference

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

21 January 2018

1 reference

Pravastatin Therapy and the Risk of Stroke

21 January 2018

1 reference

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association

21 January 2018

1 reference

Impact of dyslipidaemia in renal transplant recipients

21 January 2018

1 reference

Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis

21 January 2018

1 reference

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency

21 January 2018

1 reference

Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins.

21 January 2018

1 reference

Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression

21 January 2018

1 reference

Patient survival after renal transplantation III: the effects of statins

21 January 2018

1 reference

ACC/AHA/NHLBI clinical advisory on the use and safety of statins

21 January 2018

1 reference

Primary Prevention of Ischemic Stroke

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C499

1 reference

6 August 2017

1 reference